Search - tctmd.com

Displaying 1 - 20 of 26

Sort: Relevancy | Date

Will Tricuspid Innovation Outpace Mitral? Some Hopes, Some Second-Guessing

Shelley Wood

December 07, 2022

News Daily News

Left-Sided Bioprosthetic Valves Often Dysfunctional in Pregnant Women

L.A. McKeown

November 21, 2022

News Daily News

Another DOAC Fails in the Setting of Mechanical Heart Valves

Todd Neale

September 28, 2022

News Conference News TCT 2022

Valve Fracture for ViV TAVI Linked With Higher Mortality

Michael O'Riordan

September 22, 2022

Presentation TCT 2022

Thrombosis, HALT, and Bleeding Risk

Presenter: Gagan D. Singh

September 19, 2022

Presentation TCT 2022

TCT 361: On the Likelihood of Leaflet Thrombosis following Transcatheter Pulmonary Valve Replacement

Presenter: Mina Shafiei

September 19, 2022

Presentation TCT 2022

TCT 360: The Importance of Leaflet Design in Initiation and Growth of Leaflet Thrombosis in Transcatheter Aortic Valves

Presenter: Ali Azadani

September 19, 2022

News Conference News TCT 2022

As Time Goes By, Post-TAVI Thrombus Becomes More OAC Resistant

Michael O'Riordan

September 18, 2022

Presentation TCT 2022

TCT 380: Predicting Device Related Thrombosis Using Computational Fluid Dynamics

Presenter: Brennan Vogl

September 18, 2022

News Conference News TCT 2022

FLASH: More Data to Support Mechanical Thrombectomy in PE

L.A. McKeown

September 18, 2022

News Daily News

PFO Closure in Adults Over 60 Safe, but Patient Selection Key

Yael L. Maxwell

July 01, 2022

News Daily News

Medtronic Recalls Batteries in Some HeartWare VAD Systems

L.A. McKeown

June 23, 2022

News Conference News TVT 2022

Surgical Explant or Redo for TAVI Failures? Some Registry Insights

Michael O'Riordan

June 10, 2022

Presentation TVT 2022

Valve thrombosis remains a big issue: Data on TAVI and surgical valve

Presenter: Blake Gardner

June 09, 2022

News Daily News

Subclinical Thrombosis After TAVI Benign, at Least to 3 Years

Michael O'Riordan

June 07, 2022

News Conference News EuroPCR 2022

Thrombotic vs Bleeding Risks Post-TAVI: Insights From GALILEO

Yael L. Maxwell

May 23, 2022

News Conference News SCAI 2022

SCAI PFO Closure Guideline Addresses Real-world Patient Scenarios

L.A. McKeown

May 20, 2022

News Conference News EuroPCR 2022

Better Durability With Self-Expanding TAVI? Clues From UK TAVI

Shelley Wood

May 18, 2022

News Conference News ACC 2022

ADAPT-TAVR: Edoxaban No Better Than DAPT After TAVI

Todd Neale

April 05, 2022

Presentation ACC 2022

Edoxaban Versus Dual Antiplatelet Therapy For Valve Thrombosis And Cerebral Thromboembolism After Transcatheter Aortic-valve Replacement: A Randomized ADAPT-TAVR Trial

Presenter: Duk-Woo Park

April 04, 2022

Advertisement

Will Tricuspid Innovation Outpace Mitral? Some Hopes, Some Second-Guessing

Left-Sided Bioprosthetic Valves Often Dysfunctional in Pregnant Women

Another DOAC Fails in the Setting of Mechanical Heart Valves

Valve Fracture for ViV TAVI Linked With Higher Mortality

Thrombosis, HALT, and Bleeding Risk

TCT 361: On the Likelihood of Leaflet Thrombosis following Transcatheter Pulmonary Valve Replacement

TCT 360: The Importance of Leaflet Design in Initiation and Growth of Leaflet Thrombosis in Transcatheter Aortic Valves

As Time Goes By, Post-TAVI Thrombus Becomes More OAC Resistant

TCT 380: Predicting Device Related Thrombosis Using Computational Fluid Dynamics

FLASH: More Data to Support Mechanical Thrombectomy in PE

PFO Closure in Adults Over 60 Safe, but Patient Selection Key

Medtronic Recalls Batteries in Some HeartWare VAD Systems

Surgical Explant or Redo for TAVI Failures? Some Registry Insights

Valve thrombosis remains a big issue: Data on TAVI and surgical valve

Subclinical Thrombosis After TAVI Benign, at Least to 3 Years

Thrombotic vs Bleeding Risks Post-TAVI: Insights From GALILEO

SCAI PFO Closure Guideline Addresses Real-world Patient Scenarios

Better Durability With Self-Expanding TAVI? Clues From UK TAVI

ADAPT-TAVR: Edoxaban No Better Than DAPT After TAVI

Edoxaban Versus Dual Antiplatelet Therapy For Valve Thrombosis And Cerebral Thromboembolism After Transcatheter Aortic-valve Replacement: A Randomized ADAPT-TAVR Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content